Novartis AG (NEO:NVS)
Canada flag Canada · Delayed Price · Currency is CAD
22.35
+0.04 (0.18%)
Jun 2, 2025, 4:00 PM EDT
-3.12%
Market Cap 316.42B
Revenue (ttm) 76.50B
Net Income (ttm) 18.48B
Shares Out n/a
EPS (ttm) 9.17
PE Ratio 17.12
Forward PE 14.14
Dividend n/a
Ex-Dividend Date n/a
Volume 2,800
Average Volume 920
Open 22.35
Previous Close 22.31
Day's Range 22.35 - 22.35
52-Week Range 20.11 - 24.03
Beta n/a
RSI 62.67
Earnings Date Jul 17, 2025

About Novartis AG

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Re... [Read more]

Sector Healthcare
Founded 1996
Employees 75,883
Stock Exchange Cboe Canada
Ticker Symbol NVS
Full Company Profile

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.